Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medical Economics|October 30, 2015
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspectiveStéphane Roze, Jayne Smith-Palmer, William J Valentine, et al.
Advances in Therapy|February 28, 2022
Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The NetherlandsErik H Serné, Stéphane Roze, Maria I Buompensiere, et al.
Diabetes Technology & Therapeutics|July 1, 2026
Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 DiabetesDanila Fava, Asli Zeynep Ozdemir Saltik, Richard F Pollock, et al.
Diabetes Technology & Therapeutics|September 19, 2025
Improving Time-in-Range in Type 1 Diabetes: Projecting the Clinical and Cost Implications of Automated Insulin DeliverySufyan Hussain, Asli Zeynep Ozdemir Saltik, Jessica J Yu, et al.
Diabetes Technology & Therapeutics|October 6, 2023
A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 DiabetesJohan Jendle, Maria Ida Buompensiere, Asli Zeynep Ozdemir Saltik, et al.
Arthritis Research & Therapy|December 17, 2005
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective studyFabiola Atzeni, Piercarlo Sarzi-Puttini, Donata Dell' Acqua, et al.
Diabetes Technology & Therapeutics|December 28, 2021
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in GreeceVaia Lambadiari, Asli Zeynep Ozdemir Saltik, Simona de Portu, et al.
Diabetes Technology & Therapeutics|October 17, 2018
Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as OutcomesHarold W De Valk, Sandrine Lablanche, Emanuele Bosi, et al.
Diabetes Technology & Therapeutics|August 5, 2015
The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise StudyIgnacio Conget, Javier Castaneda, Goran Petrovski, et al.
Diabetes, Obesity & Metabolism|April 5, 2017
Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trialMuriel Metzger, Javier Castañeda, Yves Reznik, et al.
Pageof 5